Reflections from Cell and Gene Meeting on the Mesa 2021
I recently had the privilege of both presenting at and attending the 2021 Alliance for Regenerative Medicine (ARM) Annual Cell
I recently had the privilege of both presenting at and attending the 2021 Alliance for Regenerative Medicine (ARM) Annual Cell
Advarra conducted The Future of the Clinical Research Workforce survey in Summer 2021. This report reflects the survey’s findings.
Transcript The way we conduct clinical research is changing. More studies now require oversight from an independent Data Monitoring Committee
Understanding when to use a Data Monitoring Committee (DMC) is crucial for participant safety. A DMC independently reviews data to spot early evidence of harm.
Establishing DSMB independence helps mitigate bias, ensuring clinical trials adhere to regulatory standards and build public trust.
A well-managed, participant-centric clinical trial has many moving parts, and easy access to the right technologies, services, and community of
Informed consent, a cornerstone of ethical research, involves describing important elements of research in a way that permits participants or
Download a larger version of the infographic. IRBs and Researchers: Know Your US Medical Device Documentation Speed the IRB
Phase I research demands careful IRB oversight, balancing participant safety with timely reviews. Proactive strategies can help address its unique challenges.
When an institutional review board (IRB) determines research is “minimal risk” (as defined in Department of Health and Human Services
Learn how to navigate ethical issues in decentralized research with insights for sponsors and IRBs on design and deployment strategies.
Diversity and Inclusion: Who is Responsible – Site, CRO or Sponsor? Attaining a diverse trial patient population is crucial to